<p>Participants: Healthy older adults </p>
<p>Dosage: 1 mg/day of rapamycin for 8 weeks </p>


Older adults taking low-dose rapamycin exhibit a reduction in senescent cells — cells that contribute to age-related diseases and a shorter lifespan. 

Associate professor at Oxford University and corresponding author on the study, Lynne S Cox, MA, PhD (image: researchgate.com).

Immunity

Supplements like NAD+ boosters may benefit older individuals, while drugs like metformin and interventions such as physical exercise may not, according to German scientists. 

Aging &amp; Longevity

A vaccine targeting an enzyme that breaks down NAD+, called CD38, counteracts signs of aging in mice. 


A 167-study analysis reveals that rapamycin prolongs lifespan as effectively as dietary restriction: reducing food intake without entering a state of malnourishment.

Latest Human Trial from the Buck Institute Shows Plasma Exchange Lowers Biological Age

A new human study shows that a procedure involving the replacement of blood plasma with a fresh solution (therapeutic plasma exchange) lowers a measure of how quickly the body is aging (biological age).

(The Buck Institute for Research on Aging | Facebook)

In a first-of-its-kind human trial, participants who underwent therapeutic plasma exchange exhibited significantly lowered biological age.

Search Result: Glucose

New Oxford Study: Powerful Longevity Drug Rapamycin Targets Cell Senescence

New Findings: Anti-Aging Supplements Are Not “One-Size-Fits-All”

Anti-Aging Vaccine Boosts Strength, Memory & NAD+ in New Study

Anti-Aging Drug Rapamycin Extends Life as Much as Dieting, New Study Shows

Latest Human Trial from the Buck Institute Shows Plasma Exchange Lowers Biological Age